Delaware
(State
or Other Jurisdiction
of
Incorporation)
|
000-30929
(Commission
File Number)
|
13-4087132
(IRS
Employer Identification No.)
|
£ |
Written
communications pursuant to Rule 425 under the Securities
Act.
|
£ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 14d-2b under the Exchange
Act.
|
£ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange
Act.
|
Exhibit
Number
|
Description | |
99.1
|
Press Release dated April 4, 2008. |
Keryx
Biopharmaceuticals, Inc.
(Registrant)
|
||
Date: April 4, 2008 | ||
|
|
|
By: |
/s/ Beth F. Levine
|
|
Beth
F. Levine
Senior
Vice President, Chief Compliance
Officer, General Counsel and Secretary |
Exhibit
Number
|
Description | |
99.1
|
Press Release dated April 4, 2008. |